Gold University of Minnesota M. Skip to main content.University of Minnesota. Home page.
 
OVPR Banner.
What's Inside
About OVPR

Policies, Regulations, and Compliance

Training

Information for Businesses

Funding and Opportunities

Colleges, Centers, and Institutes

Communications

Forms and Electronic Tools  
Related Links

The Graduate School

Postdoctoral Affairs

Experts@Minnesota

Electronic Grants Management System (EGMS)

Academic Health Center Research

UM-Crookston Research

UM-Duluth Research

UM-Morris Research

 
 
Office of the Vice President for Research
Search OVPR | Contact OVPR  
  Home > Spotlight > Timothy Tracy

One Size Doesn't Fit All
Pharmacy professor Timothy Tracy studies the unique medication needs of pregnant women

photo of Timothy Tracy

Timothy Tracy
Pharmacy

 


New Grant

Timothy Tracy recently received a $982,425 grant to study how the body processes drugs-findings that could decrease dangerous drug interactions. He hopes to develop a set of rules that will predict how certain drugs will behave in the body. Ultimately, these rules will reduce or eliminate the need to pull drugs from the market because of unforeseen drug interactions. The discoveries could also increase the number of new drugs brought to market because manufacturers will better understand drug interactions. Ultimately, this knowledge will save lives.

 

When a physician writes a prescription for a patient, the dose is often based on studies that until recent years have been conducted exclusively on healthy men. This could pose a problem for women, whose bodies process medications differently than men's. Pregnant women are of even greater concern, as their bodies metabolize different drugs at different rates during each trimester. As healthy women are now included in dosing studies, researchers at the University of Minnesota are looking at the unique needs of pregnant women.

Timothy Tracy, a professor in the Department of Experimental and Clinical Pharmacology, has published findings that will help pregnant women receive the right dose of medication to manage chronic conditions such as diabetes, depression, or HIV during each stage of pregnancy. Tracy notes that a pregnant woman's ability to metabolize medications depends on the stage of pregnancy and the medication taken-dosages can't be determined by a one-size-fits-all approach. "The dose a woman needs in pregnancy may need to be changed throughout her pregnancy," he says.

Researchers knew pregnant women needed to have their medications adjusted, but they didn't know by how much and whether to increase or decrease dosages. Tracy's findings show that dosage adjustments depend on the stage of pregnancy and the medication."You can't treat all medications the same," Tracy says.

"You can't say 'She's pregnant so we automatically have to increase or decrease the medication.'"

In the study, pregnant women were given two drugs known to be safe during pregnancy-caffeine and dextromethorphan, a cough suppressant that is available without a prescription. These are considered "marker drugs" since they are broken down by specific enzymes in the body. Pregnant women were given the drugs three times: Between the 14th and 18th weeks, between the 24th and 28th weeks, and between the 36th and 40th weeks of pregnancy. They were also given the drugs between six and eight weeks after giving birth.

Three enzymes in the body metabolize about 80 percent of medications-including caffeine and dextromethorphan. Tracy studied the concentration of these drugs after they were ingested to determine whether metabolism of medication increased or decreased throughout pregnancy.

Tracy found pregnant women's metabolism of some medications increases or decreases only once during pregnancy, while metabolism of other medications continues to increase or decrease as pregnancy progresses. The change depends on which enzyme the body uses to metabolize the drug. Researchers can now correlate the findings to the 80 percent of medications metabolized by these enzymes. That means more accurate and safer dosing guidelines for medications women need to manage their chronic conditions as their bodies change during pregnancy.

The findings from Tracy's research were published in the February issue of the American Journal of Obstetrics and Gynecology.

Asking the right questions, giving complete answers

In another study, Tracy looked at the disparity between information pregnant women give their physicians about medication use and what drugs they actually take. According to the study, what information women perceive as important to tell their obstetrician and what the physician deems important are often two different things. Throughout the study, researchers interviewed 700 pregnant women using a three-tiered process. "We asked what prescription medications are you taking and why, what over-the-counter medications and why, and what herbal medications are you taking and why," says Tracy. Then they asked what medications the patient would take for a headache and other common conditions. The interviewer finished by listing additional medications to jog the patient's memory. At each stage of the questioning, most patients remembered additional medications that they take regularly. The study's findings show that both patients and physicians need to be aware of the importance of sharing and obtaining accurate information, especially in assessing drug interactions. "We need to make it such that we can make the best decisions for your health," says Tracy.

OVPR Logo
 
The University of Minnesota is an equal opportunity educator and employer.